Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

about

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

Item

http://www.wikidata.org/entity/Q47741344

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@en

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@nl

type

Item

label

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@en

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@nl

prefLabel

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@en

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@nl

P1476

Haemodilution is a mechanism of anaemia in patients with heart failure: reply.

@en

P2093

B Daan Westenbrink

http://www.w3.org/2001/XMLSchema#string

Lennaert Kleijn

http://www.w3.org/2001/XMLSchema#string

Peter van der Meer

http://www.w3.org/2001/XMLSchema#string

P2860

Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

Anemia in chronic heart failure: etiology and treatment options.

Erythropoietin in cardiac disease: new features of an old drug.

Thrombotic complications of erythropoiesis-stimulating agents.

Erythropoietin and heart failure: the end of a promise?

The predictive value of short-term changes in hemoglobin concentration in patients presenting with acute decompensated heart failure.

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

Haemodilution is a mechanism of anaemia in patients with heart failure.

Treatment of anemia with darbepoetin alfa in systolic heart failure.

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

P304

1075-1076

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURJHF/HFT131

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23960086

http://www.w3.org/2001/XMLSchema#string